Brentuximab Vedotin: Powder for I.V. infusion 50 mg; Adcetris® Page last updated: 19 July 2024 Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 849KB) Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 530KB)